RedHill Pharma Raises $20M

January 20, 2014 | Israeli biopharmaceutical company RedHill Biopharma has announced that it has raised $20 million over two consecutive weeks. The company, which acquires drugs and treatments in late clinical trial stages and then finalizes development, raised some of the money from VCs and some in the form of a share offering.